Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
European Urology
|
April 24, 2007
Editorial comment on: Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors
Tommaso Prayer-Galetti
Urologia
|
March 21, 2019
Is digital rectal examination still useful in prostate cancer diagnosis? YES!
Tommaso Prayer Galetti
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
January 13, 2006
[Prostate biopsy: staging values]
Stefano De Luca, Alessandro Bertaccini, Tommaso Prayer Galetti, et al.
Urologia
|
May 8, 2014
[Positive surgical margins after radical prostatectomy]
Tommaso Prayer Galetti, Francesco Cattaneo, Irena Coati, et al.
Frontiers in Oncology
|
March 27, 2020
Metabolic Plasticity in Chemotherapy Resistance
Maria Andrea Desbats, Isabella Giacomini, Tommaso Prayer-Galetti, et al.
BJU International
|
March 29, 2006
Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer
Peter G Hammerer, Michael W Kattan, Nicolas Mottet, et al.
BJU International
|
March 29, 2006
Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer
Nicolas Mottet, Tommaso Prayer-Galetti, Peter Hammerer, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
January 13, 2006
[When to carry out prostate biopsy]
Tommaso Prayer-Galetti, Vincenzo Ficarra, Roberta Franceschini, et al.
Analytical and Quantitative Cytology and Histology
|
May 9, 2007
Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer
Tommaso Prayer-Galetti, Marina Gardiman, Emilio Sacco, et al.
BJU International
|
July 31, 2007
The role of intermittent androgen deprivation in prostate cancer
Laurent Boccon-Gibod, Peter Hammerer, Stephan Madersbacher, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
European Urology
|
April 24, 2007
Editorial comment on: Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors
Tommaso Prayer-Galetti
Urologia
|
March 21, 2019
Is digital rectal examination still useful in prostate cancer diagnosis? YES!
Tommaso Prayer Galetti
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
January 13, 2006
[Prostate biopsy: staging values]
Stefano De Luca, Alessandro Bertaccini, Tommaso Prayer Galetti, et al.
Urologia
|
May 8, 2014
[Positive surgical margins after radical prostatectomy]
Tommaso Prayer Galetti, Francesco Cattaneo, Irena Coati, et al.
Frontiers in Oncology
|
March 27, 2020
Metabolic Plasticity in Chemotherapy Resistance
Maria Andrea Desbats, Isabella Giacomini, Tommaso Prayer-Galetti, et al.
BJU International
|
March 29, 2006
Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer
Peter G Hammerer, Michael W Kattan, Nicolas Mottet, et al.
BJU International
|
March 29, 2006
Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer
Nicolas Mottet, Tommaso Prayer-Galetti, Peter Hammerer, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
January 13, 2006
[When to carry out prostate biopsy]
Tommaso Prayer-Galetti, Vincenzo Ficarra, Roberta Franceschini, et al.
Analytical and Quantitative Cytology and Histology
|
May 9, 2007
Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer
Tommaso Prayer-Galetti, Marina Gardiman, Emilio Sacco, et al.
BJU International
|
July 31, 2007
The role of intermittent androgen deprivation in prostate cancer
Laurent Boccon-Gibod, Peter Hammerer, Stephan Madersbacher, et al.
Page
of 6